Homepage - Visible | Swissmedic

Investigated

When software counts as a medical device It's all down to the intended use

Presented

The road to authorisation The requirements, the steps to take and current challenges

Probed

Our strategic objectives The Council’s view

Highlighted

Some facts and figures – newly illustrated

Globalised

Development cooperation Making medicines available faster

Accompanied

A discussion with Professor George Coukos The huge potential of ATMP – advanced therapy medicinal products

Examined

Swissmedic Enforcement, part 1

Karoline Mathys, Head of Market Surveillance, talks about surveillance and enforcement activities. A team of inspectors from the Medical Devices Surveillance (MDS) Division – Thomas Hunkeler, Maria Bofan and Stefan Zysset – explains.